Autoimmune diseases are diseases in which the body’s own immune system attacks one or more organ systems in the body resulting in injury to the body and illness.The purpose of this study is to test a potential new treatment for autoimmune diseases.

3 nights
6 visits

For this initial stage of research, we require healthy participants to assess to safety and tolerability of the medication, how it is absorbed in the bloodstream, and whether you develop antibodies to the drug. If this study is successful, in later stages the medication will be tested with people who have autoimmune conditions such as cold agglutinin disease (CAD), warm autoimmune hemolytic anemia (wAIHA), and eye conditions such as glaucoma.

The trial has been approved by an independent ethics committee and you will be reimbursed for your time.

Eligibility

Biological Sex Healthy males and females
Age 18 - 59 years old
BMI 18 - 30 kg/m² (participants of Asian descent must have a BMI of less than 27)
Weight 50 - 125 kg
Medication Not taking any (vitamins & contraceptives permitted)
Medical History Nothing significant
Smoking History Non smokers